Aurélie Camard

Aurélie Camard intervient principalement sur des transactions privées, nationales et transfontalières, conseillant les clients français et étrangers du cabinets sur des opérations d’acquisition, de cession, de fusion, de joint-ventures et autres opérations de réorganisation. La pratique d'Aurélie Camard comprend également les questions générales de droit des sociétés.

Elle a plus de 10 ans d'expérience et représente des clients dans divers domaines, notamment dans les secteurs de l'énergie, de l'industrie, des nouvelles technologies et de la pharmaceutique.

Dans le secteur de l'énergie, Aurélie Camard représente TotalEnergies dans le cadre de différents projets. Elle représente également régulièrement Sanofi, l'un des principaux groupes pharmaceutiques français, dans le cadre de cession de portefeuilles de produits.

Aurélie Camard a également acquis une grande expérience dans les secteurs de la défense, des sciences de la vie et des services financiers dans le cadre de diverses opérations de fusions-acquisitions et droit des sociétés.

Expérience

EDF and Abraxas Power announce strategic partnershipJones Day advised EDF (Electricité de France) in its joint venture with Abraxas Power Corp., a leading energy transition developer to develop a 3+ Gigawatts (GW) green hydrogen (from onshore wind) and green ammonia production in Central Newfoundland, Canada.

Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.

Sanofi sells two established product portfolios to NeuraxpharmJones Day advised Sanofi in the sale of 2 portfolios of products for central nervous systems disorders and pain and vascular diseases to LESVI, a Spanish subsidiary of Neuraxpharm.

Électricité de Strasbourg forms JV with ErametJones Day advised Électricité de Strasbourg, an energy provider in Alsace (France), in the formation of a joint venture with Eramet, one of the leading French actors in the mining and metallurgy industries, to develop and use joint capabilities for the extraction, refining and production of lithium from geothermal resources, with a targeted annual volume of 10,000 tons of lithium corresponding to the volume necessary to produce c.250,000 batteries for electric vehicles per year).

Timken acquires GGB Bearing Technology for $305 millionJones Day advised The Timken Company in the $305 million acquisition of GGB Bearing Technology (GGB), a division of Enpro, Industries (including exclusive negotiations with respect to the French operations of GGB).

Counsel

Contact

Expérience

Aurélie Camard

Counsel

Contact

Partager

Domaines d’intervention

Bureaux

Formation

Barreaux et juridictions

Distinctions

Langues parlées